10x Genomics
TXG
#4404
Rank
HK$14.72 B
Marketcap
HK$121.60
Share price
-3.28%
Change (1 day)
-56.11%
Change (1 year)

P/E ratio for 10x Genomics (TXG)

P/E ratio as of November 2024 (TTM): -10.5

According to 10x Genomics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -10.4966. At the end of 2022 the company had a P/E ratio of -24.8.

P/E ratio history for 10x Genomics from 2019 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-24.8-91.35%
2021-286941.86%
2020-27.5-79.77%
2019-136

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-9.38-10.67% Jersey
-1.24-88.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.1950-98.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.69-74.34%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.